New test could match ovarian cancer patients to the right drug
Knowledge-focused
Recruiting now
This study is testing a device called a Drug Response Predictor (DRP) that uses a sample of a patient's tumor to see if it will respond to certain cancer drugs. The trial involves 60 people with advanced ovarian cancer that has stopped responding to platinum chemotherapy. The goa…
Sponsor: Allarity Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC